Related Experiment Video
Updated: Jul 2, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Endothelial dysfunction in recently diagnosed type 2 diabetic patients evaluated by PET
Erick Alexanderson1, Mónica Rodriguez-Valero, Alfonso Martinez
1Universidad Nacional Autonoma de Mexico, Mexico City. alexanderick@yahoo.com
Molecular Imaging and Biology
|September 5, 2008
Summary
Asymptomatic type 2 diabetes patients show endothelial dysfunction (ED) detectable by (13)N-ammonia-positron emission tomography (PET). This imaging technique quantifies myocardial blood flow changes, revealing ED even in early disease stages.
Area of Science:
- Cardiology
- Nuclear Medicine
- Diabetology
Background:
- Endothelial dysfunction (ED) is an early indicator of cardiovascular complications in type 2 diabetes mellitus (DM).
- Non-invasive imaging is crucial for detecting ED in asymptomatic diabetic patients.
- Positron emission tomography (PET) offers quantitative assessment of myocardial perfusion.
Purpose of the Study:
- To ascertain the presence of endothelial dysfunction (ED) in asymptomatic type 2 diabetes mellitus (DM) patients.
- To utilize (13)N-ammonia-positron emission tomography (PET) for quantifying myocardial blood flow (MBF) and assessing endothelial function.
- To establish markers like endothelial-dependent vasodilation index (EDVI) and myocardial flow reserve (MFR) for ED detection.
Main Methods:
- Studied 39 subjects: 22 recently diagnosed type 2 diabetic patients and 17 healthy controls (HC).
- Performed a three-phase (13)N-ammonia-PET scan to measure MBF at rest, during cold pressor test (CPT), and pharmacologic stress.
- Calculated EDVI, MFR, and %DeltaMBF, normalizing values to the rate-pressure product (RPP) for corrected EDVI' and %DeltaMBF'.
Main Results:
- Diabetic patients exhibited significantly lower mean EDVI' (0.864 vs. 1.110, p=0.004) and %DeltaMBF' (-8.2% vs. 4.5%, p=0.005) compared to healthy controls.
- While MFR showed no significant difference (p=NS), the %DeltaMBF was markedly reduced in diabetic individuals (20% vs. 55%, p=0.002).
- These findings indicate impaired endothelial-dependent vasodilation in asymptomatic type 2 diabetes.
Conclusions:
- Asymptomatic, recently diagnosed type 2 diabetes patients demonstrate significant endothelial dysfunction.
- (13)N-ammonia-PET is a valuable tool for quantifying ED in this patient population.
- Early detection of ED using PET can inform risk stratification and management strategies for type 2 diabetes.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...